BMO Capital Markets expressed confidence in Gilead Sciences (NASDAQ:GILD), with analyst Evan David Seigerman increasing the company's price target to $115 from the previous $110, while maintaining an ...

There is no question that tariffs will increase the input costs of key components in housing like flooring, millwork, and ...

Allstate has improved its cost structure and underwriting, but I remain skeptical about its growth prospects, especially in ...

The company reported revenue of $219 million and earnings of $0.26 per share, surpassing the consensus estimates of $181 ...

Canada's Barrick Gold Corporation exceeded analysts' expectations for fourth-quarter profit, reporting higher earnings than ...

So far, BSX stock has risen 19% year-to-date. Looking at a longer period, BSX has been a strong performer, surging 129% since ...

| With budget reconciliation right around the corner, different slices of the healthcare industry have made their views clear on issues like physician pay, ACA subsidies, telehealth flexibilities, ...

Board Chair Kathryn Barger cited a disturbing trend of price gouging, preying on the most vulnerable communities.

Stifel Financial is a top pick for long-term growth with solid Q424 results, a 10% dividend hike & solid wealth management ...

After a rough 2024, Teladoc Health (TDOC) has seen its shares surge up roughly 45% year-to-date, catalyzed by a recent ...

With the Brazilian real declining steadily versus the dollar, US investors have fared even more poorly: average monthly revenue per wireless customer at TIM dropped to $4.70 in 2021 from $6.60 in 2013 ...